SEC Form 4 · accession 0001522767-26-000155
MARIMED INC. · MRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eva Selhub M.D.
Director
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001522767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jul 15, 2026 | M | 173,077 | $0.00 | A | 730,748 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSU)F1,F2 | — | Jul 15, 2026 | A | 173,077 | A | — | — | Common Stock, par value $.001 per share | 173,077 | 173,077 | D |
| Restricted Stock Units (RSU)F1,F2 | — | Jul 15, 2026 | M | 173,077 | D | — | — | Common Stock, par value $.001 per share | 173,077 | 0 | D |
Explanation of responses
- F1RSUs convert to shares of common stock on a one-for-one basis.
- F2The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.
Remarks
The RSUs were granted in lieu of cash as payment for a portion of the Reporting Person's fees for serving on the Issuer's Board of Directors.